futureTEKnow covers technology, startups, and business news, highlighting trends and updates across AI, Immersive Tech, Space, and robotics.
Linkedin X-twitter-square Facebook-square

OpenEvidence’s $210M Leap: How AI Agents Are Transforming Medical Research

By futureTEKnow | Editorial Team

KEY POINTS

  • $210M Series B Funding at a $3.5B valuation.

  • 10,000+ hospitals and 40% of US physicians use OpenEvidence daily.

  • AI integrates with top-tier medical journals for evidence-based responses.

  • DeepConsult™: AI-powered, PhD-level agents conduct in-depth research autonomously.

  • Offered free to US clinicians, addressing burnout and the information overload crisis.

OpenEvidence raises $210M to advance AI-powered medical research, revolutionizing clinical insights for US physicians and healthcare innovation.

In a move that could reshape the future of medical decision-making, OpenEvidence has secured a staggering $210 million in Series B funding, sending shockwaves through both the health tech sector and investment circles. Now valued at $3.5 billion, the Cambridge-based company’s mission is clear: bring real-time, evidence-based insights to the fingertips of clinicians using artificial intelligence built for the unique demands of modern healthcare.

OpenEvidence Platform is FREE for verified U.S. HCPs. | Source: OpenEvidence.com
OpenEvidence Platform is FREE for verified U.S. HCPs. | Source: OpenEvidence.com

AI at the Heart of the Hospital

The adoption curve for OpenEvidence has been nothing less than remarkable. Already active in over 10,000 hospitals and reaching 40% of US physicians, the platform is embedded into the daily rhythm of healthcare. Its secret sauce? Combining AI-powered search with partnerships spanning the American Medical Association, JAMA, and The New England Journal of Medicine—bringing trustworthy, peer-reviewed research right to the bedside.

These integrations allow OpenEvidence to sidestep the traditional scavenger hunt through fragmented databases. Instead, clinicians ask complex patient-specific questions and, within seconds, receive tailored, referenced responses—speeding up care, reducing cognitive overload, and sharply cutting research time from hours to moments.

DeepConsult™: Your AI Research Team

The latest announcement turns up the dial: OpenEvidence DeepConsult™, a team of autonomous, PhD-level, medically-specialized AI agents designed for the research needs of busy physicians. Imagine asking a time-consuming question before seeing your next patient, then returning from a break to find a comprehensive research synthesis ready in your inbox. DeepConsult efficiently cross-references hundreds of studies, surfacing critical insights and even uncovering interdisciplinary connections that might otherwise go unnoticed.

For US doctors, DeepConsult™ is free, making advanced medical research as accessible as a tap on the screen—an answer to the overwhelming expansion of medical knowledge and the burnout plaguing healthcare professionals.

Addressing Healthcare’s Growing Crisis

These innovations arrive as the industry faces a critical physician shortage and a relentless increase in the volume of medical research. OpenEvidence’s AI—trusted, fast, and always up-to-date—acts as a copilot for clinicians, empowering them to deliver the best care possible despite the pressures of understaffed hospitals and rapidly evolving medical science.

“Physicians are superheroes, and OpenEvidence is giving these superheroes new superpowers,” notes founder Daniel Nadler, underscoring the company’s commitment to making complex data actionable and keeping care at the cutting edge.

futureTEKnow covers technology, startups, and business news, highlighting trends and updates across AI, Immersive Tech, Space, and robotics.

futureTEKnow

Editorial Team

futureTEKnow is a leading source for Technology, Startups, and Business News, spotlighting the most innovative companies and breakthrough trends in emerging tech sectors like Artificial Intelligence (AI), immersive technologies (XR), robotics, and the space industry.

Latest Articles

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >